Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 48 240.9 |
96 | EP file number | EAKZ | 01 93 4399.5 |
86 | WO file number | WAKZ | PCT/JP01/04520 |
97 | EP publication number | EPN | 1428538 |
87 | WO publication number | WPN | 2001091795 |
54 | Designation/title | TI | FÖRDERER DER ECTOCORNEAL-AUSWEITUNG |
51 | IPC main class | ICM (ICMV) | A61K 45/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/7072 (2006.01), A61K 31/7076 (2006.01), A61K 31/7084 (2006.01), A61P 27/02 (2006.01), C07H 19/10 (2006.01), C07H 19/20 (2006.01) |
22 | DE application date | DAT | May 30, 2001 |
96 | EP application date | EAT | May 30, 2001 |
86 | WO application date | WAT | May 30, 2001 |
43 | Date of first publication | OT | Dec 6, 2001 |
| Date of publication of grant | PET | Aug 14, 2013 |
71/73 | Applicant/owner | INH | Merck Sharp & Dohme Corp., Rahway, N.J., US; Santen Pharmaceutical Co., Ltd, Osaka, JP |
72 | Inventor | IN | FUJIHARA, Tsutomu, Ikoma-shi,Nara 630-0101, JP; NAKATA, Katsuhiko, Ikoma-shi,Nara 630-0101, JP; FUJITA, Hiromi, Ikoma-shi,Nara 630-0101, JP; NAKAMURA, Masatsugu, Ikoma-shi,Nara 630-0101, JP |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| JP 2000159889 May 30, 2000
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | SF - Sonstige Fremdsprache |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001428538 Searchable text:
EP000001428538 Original document:
EP000001428538B1 Searchable text:
EP000001428538B1 Original document:
WO002001091795 Searchable text:
WO002001091795 |
43 | Date of first publication | EVT | Dec 6, 2001 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 1, 2021 (Show all update days)(Hide all update days)- Jun 1, 2021; Apr 22, 2020; Aug 16, 2019; Apr 18, 2019; Oct 26, 2018; May 24, 2018; Jun 22, 2017; Jun 9, 2017; Jun 9, 2016; Oct 26, 2015; Jun 17, 2015; Apr 15, 2015; Feb 26, 2015; Jan 21, 2015; Aug 28, 2014; Jul 24, 2014; Jun 27, 2014; Jun 12, 2014; Oct 10, 2013; Sep 5, 2013; Aug 30, 2013; Aug 18, 2013; Aug 15, 2013; Jan 26, 2013; Dec 22, 2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 12)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 20, 2015 |
| Issue number | HN | 9 |
| Year | PJ | 2015 |
| Publication date | VT | Feb 26, 2015 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Merck Sharp & Dohme Corp., Rahway, N.J., US; Santen Pharmaceutical Co., Ltd, Osaka, JP |
71/73 | Previous applicant/owner | INHF | Santen Pharmaceutical Co., Ltd, Osaka, JP, Inspire Pharmaceuticals, Durham, N.C., US |